ZA202000609B - Novel composition of enzalutamide oral dosage form and method of manufacturing thereof - Google Patents
Novel composition of enzalutamide oral dosage form and method of manufacturing thereofInfo
- Publication number
- ZA202000609B ZA202000609B ZA2020/00609A ZA202000609A ZA202000609B ZA 202000609 B ZA202000609 B ZA 202000609B ZA 2020/00609 A ZA2020/00609 A ZA 2020/00609A ZA 202000609 A ZA202000609 A ZA 202000609A ZA 202000609 B ZA202000609 B ZA 202000609B
- Authority
- ZA
- South Africa
- Prior art keywords
- enzalutamide
- manufacturing
- dosage form
- oral dosage
- novel composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201721023465 | 2017-07-04 | ||
PCT/IB2017/057273 WO2019008426A1 (en) | 2017-07-04 | 2017-11-21 | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA202000609B true ZA202000609B (en) | 2021-08-25 |
Family
ID=64950639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2020/00609A ZA202000609B (en) | 2017-07-04 | 2020-01-29 | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof |
Country Status (7)
Country | Link |
---|---|
BR (1) | BR112020000207A2 (en) |
CL (1) | CL2020000017A1 (en) |
MX (1) | MX2020000213A (en) |
PH (1) | PH12020500045A1 (en) |
RU (1) | RU2020105102A (en) |
WO (1) | WO2019008426A1 (en) |
ZA (1) | ZA202000609B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR118925A1 (en) * | 2020-05-13 | 2021-11-10 | Novocap S A | CONCENTRATED LIQUID SOLUTION OF NON-STEROID ANTIANDROGENS AND PROCEDURE FOR PREPARING THE SOLUTION |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160346207A1 (en) * | 2014-02-05 | 2016-12-01 | Lek Pharmaceuticals D.D. | Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists |
-
2017
- 2017-11-21 RU RU2020105102A patent/RU2020105102A/en unknown
- 2017-11-21 BR BR112020000207-0A patent/BR112020000207A2/en unknown
- 2017-11-21 MX MX2020000213A patent/MX2020000213A/en unknown
- 2017-11-21 WO PCT/IB2017/057273 patent/WO2019008426A1/en active Application Filing
-
2020
- 2020-01-03 CL CL2020000017A patent/CL2020000017A1/en unknown
- 2020-01-03 PH PH12020500045A patent/PH12020500045A1/en unknown
- 2020-01-29 ZA ZA2020/00609A patent/ZA202000609B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2020105102A (en) | 2021-08-04 |
BR112020000207A2 (en) | 2020-07-07 |
CL2020000017A1 (en) | 2020-05-22 |
PH12020500045A1 (en) | 2020-11-09 |
WO2019008426A1 (en) | 2019-01-10 |
MX2020000213A (en) | 2020-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201704985B (en) | Oral care compositions and methods of use | |
HK1246656A1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
IL273259A (en) | Manufacturing of pharmaceutical compositions | |
ZA201703763B (en) | Oral care composition and method of use | |
ZA202004531B (en) | Compositions containing thymohydroquinone and their method of preparation | |
ZA201807476B (en) | Oral care composition and method of use | |
ZA201801015B (en) | Oral care compositions and methods of using the compositions | |
EP3485886A4 (en) | Oral pharmaceutical composition of tecovirimat and preparation method therefor | |
HK1245094A1 (en) | Pharmaceutical composition for treatment of depression and preparation method thereof | |
IL250852A0 (en) | Periodontal composition and method of use | |
ZA202000609B (en) | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof | |
HK1246639A1 (en) | Oral pharmaceutical composition and method of treating or preventing disease | |
IL258304A (en) | Oral care compositions and methods of using the compositions | |
GB201708500D0 (en) | Oral care composition, process for preparation and method of use thereof | |
EP3643325C0 (en) | A composition comprising furazidin and a method of its manufacturing | |
EP4081233A4 (en) | Composition and methods of manufacture | |
PT3277266T (en) | Oral solid dosage form of amlodipine and veterinary uses thereof | |
ZA202101538B (en) | Novel composition of lapatinib of oral solid dosage form and method of manufacturing thereof | |
GB201501413D0 (en) | A confectionery composition and a method of manufacturing thereof | |
IL273904A (en) | Pharmaceutical resinate compositions and methods of making and using thereof | |
GB201719915D0 (en) | A composition and method of preparation thereof | |
GB201703964D0 (en) | Composition and method of manufacture | |
GB201701014D0 (en) | Composition and method of production thereof | |
GB201805578D0 (en) | Prebiotic compositions and methods of production thereof | |
GB201805577D0 (en) | Prebiotic compositions and methods of production thereof |